Premier Path Wealth Partners’s Biogen BIIB Stock Holding History

Premier Path Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602K	Sell	2,786 -737	-21%	-$141K	0.07%	234
2026 Q1	$646K	Sell	3,523 -2,207	-39%	-$407K	0.08%	221
2025 Q4	$1.01M	Sell	5,730 -3,313	-37%	-$541K	0.13%	157
2025 Q3	$1.27M	Sell	9,043 -508	-5%	-$68.7K	0.16%	137
2025 Q2	$1.2M	Buy	9,551 +839	+10%	+$105K	0.17%	149
2025 Q1	$1.19M	Buy	8,712 +1,156	+15%	+$165K	0.19%	138
2024 Q4	$1.16M	Buy	7,556 +1,548	+26%	+$261K	0.18%	140
2024 Q3	$1.16M	Buy	6,008 +341	+6%	+$71.3K	0.18%	141
2024 Q2	$1.31M	Buy	5,667 +392	+7%	+$85.2K	0.22%	109
2024 Q1	$1.14M	Buy	5,275 +1,450	+38%	+$340K	0.21%	125
2023 Q4	$1M	Buy	+3,825	New	+$939K	0.22%	117

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Premier Path Wealth Partners's BIIB Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its Biogen (BIIB) stake by 21% in Q2 2026, selling an estimated $141K and leaving 2,786 shares worth $602K. The position accounts for 0.07% of the portfolio, ranked #234.

Premier Path Wealth Partners first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.31M in Q2 2024. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Premier Path Wealth Partners held 2,786 shares of Biogen worth $602K as of Q2 2026.
Premier Path Wealth Partners sold 737 Biogen shares in Q2 2026, an estimated $141K.
Biogen made up 0.07% of Premier Path Wealth Partners's portfolio in Q2 2026, its #234 holding.
Premier Path Wealth Partners first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
Premier Path Wealth Partners's Biogen position peaked at $1.31M in Q2 2024.
380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.